Tech Company M&A Transactions
Arranta Bio Acquisition
On 2/18/2022, Arranta Bio was acquired by Recipharm. The financial terms of the deal were not announced.
Transaction Overview
Company Name
Acquired By
Announced On
2/18/2022
Transaction Type
M&A
Amount
Unknown
M&A Terms
The Arranta Bio acquisition expand Recipharm's biologics offerings in the United States. Financial terms were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
650 Pleasant St.
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
Arranta Bio is delivering on its vision to build the best-in-class microbiome contract development and manufacturing organization (CDMO) through the establishment of a facility dedicated to process development and cGMP clinical supply with a commercial-ready capability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Bamforth
Founder
Iain Baird
Browse more venture capital transactions:
Prev: 2/18/2022: Alma SAS venture capital transaction
Next: 2/18/2022: Sekr venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs